Clinical Trials Browser

Not yet recruiting × Gynecologic × 30 days × Clear all

NCT07294066 2026-04-15

Uniting Trusted Community Messengers to Improve Access to Cervical Cancer Screening in Rural North Carolina

Phase NA Not yet recruiting

Uterine Cervical Neoplasms

NCT07521163 2026-04-15

HBM-HPV

Phase NA Not yet recruiting

Uterine Cervical Neoplasms, Health Education, Papillomavirus Infections

NCT07530133 2026-04-15

Clinical Trial on Safety and Efficacy of Thoracoabdominal Endoscopic Surgical System for Pediatric Surgery

Phase NA Not yet recruiting

GynecologicOther neoplasm

Indications for Laparoscopic Thoracic and Abdominal Surgery in Children

NCT07530679 2026-04-15

Study on the Safety, Humoral Immune Response, and Memory B Cell Response Characteristics of Sequential 9-Valent HPV Vaccination

Phase NA Not yet recruiting

Cervical Cancer Prevention

NCT07532148 2026-04-15

Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 1 Not yet recruiting

Ovarian Neoplasms

NCT07527143 2026-04-14

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

Not yet recruiting

Endometrial Neoplasms

NCT07527819 2026-04-14

FERTILE

Not yet recruiting

BreastGynecologic

Inflammation, Primary Ovarian Insufficiency, Triple Negative Breast Neoplasms

NCT07349641 2026-04-13

A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer

Phase 2 Not yet recruiting

Endometrial Hyperplasia

NCT07504588 2026-04-13

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

Phase 2 Not yet recruiting

Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma

NCT07522697 2026-04-13

MITO END-4

Phase 2 Not yet recruiting

Hereditary Sensory and Autonomic Neuropathies, Endometrial Neoplasms

NCT07523152 2026-04-13

SAPPHIRE

Phase NA Not yet recruiting

GastrointestinalGynecologic

Anal Canal Carcinoma, Anus Neoplasms, Pelvic Neoplasms, Uterine Neoplasms, Vaginal Neoplasms

NCT07524322 2026-04-13

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Phase 1 Not yet recruiting

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT07462663 2026-04-09

SHAPE-ENDO

Not yet recruiting

GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

NCT07520188 2026-04-09

CASCADE3002

Not yet recruiting

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07189702 2026-04-08

BEND-MBEC

Phase NA Not yet recruiting

Neoplasm Metastasis, Endometrial Neoplasms

NCT07495124 2026-04-08

IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence

Phase 2 Not yet recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07514078 2026-04-07

Evaluation of Laparoscopic Staging Versus Staging Laparotomy for Early Stage Endometrial Cancer

Phase NA Not yet recruiting

Treatment Endometrial Cancer

NCT07514325 2026-04-07

MASTEC

Phase NA Not yet recruiting

Endometrial Neoplasms

NCT07516210 2026-04-07

ART-Hypo

Phase 2 Not yet recruiting

GastrointestinalGenitourinaryGynecologic

Uterine Cervical Neoplasms, Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

NCT07503054 2026-03-31

AI-OCS-Gyn

Phase NA Not yet recruiting

GynecologicSarcoma

Ovarian Cancer Screening Recommendations by Gynecologists

NCT07090109 2026-03-30

PITCH - Impacting Hereditary Cancer Testing

Phase NA Not yet recruiting

Ovarian Neoplasms

NCT06872346 2026-03-27

PREDICT

Phase NA Not yet recruiting

Uterine Cervical Neoplasms

NCT07383506 2026-03-27

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

Phase 1 Not yet recruiting

BreastGynecologic

Breast Neoplasms, Endometrial Neoplasms

NCT07489287 2026-03-27

GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer

Phase 1 Not yet recruiting

Ovarian Neoplasms

NCT07497074 2026-03-27

JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT06476639 2026-03-24

ANVU

Phase 3 Not yet recruiting

Lymphatic Metastasis, Vulvar Neoplasms

NCT07256912 2026-03-24

CervALONE

Phase 4 Not yet recruiting

Vaccine Effectiveness

NCT07489300 2026-03-24

BACON

Phase 2 Not yet recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06834204 2026-03-23

ACCESS-PC

Phase NA Not yet recruiting

GenitourinaryGynecologic

Adenocarcinoma, Urinary Bladder Neoplasms, Diabetes Mellitus, Hypercholesterolemia, Hyperlipidemias, Hypertension, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT07487168 2026-03-23

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

Phase 1 Not yet recruiting

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Colorectal Neoplasms